Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC28A3 | Q9HAS3 | 4/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | PYGB | P11216 | 1/20 | 0.47 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | TYR | P14679 | 1/20 | 0.45 |
| ▸ | CD69 | Q07108 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2429112 | 1.00 | SLC28A3 (0.50) | SLC28A3L3MBTL1MAPTPYGBLGALS8 | |
| SCHEMBL8361874 | 1.00 | SLC28A3 (0.50) | SLC28A3L3MBTL1MAPTPYGBLGALS8 | |
| SCHEMBL5862474 | 1.00 | SLC28A3 (0.50) | SLC28A3L3MBTL1MAPTPYGBLGALS8 | |
| SCHEMBL17523750 | 1.00 | SLC28A3 (0.50) | SLC28A3L3MBTL1MAPTPYGBLGALS8 | |
| SCHEMBL3144958 | 1.00 | SLC28A3 (0.50) | SLC28A3L3MBTL1MAPTPYGBLGALS8 | |
| SCHEMBL6060841 | 1.00 | SLC28A3 (0.50) | SLC28A3L3MBTL1MAPTPYGBLGALS8 | |
| SCHEMBL229613 | 1.00 | SLC28A3 (0.50) | SLC28A3L3MBTL1MAPTPYGBLGALS8 | |
| SCHEMBL22026379 | 1.00 | SLC28A3 (0.50) | SLC28A3L3MBTL1MAPTPYGBLGALS8 | |
| SCHEMBL22047951 | 1.00 | SLC28A3 (0.50) | SLC28A3L3MBTL1MAPTPYGBLGALS8 | |
| SCHEMBL19603336 | 1.00 | SLC28A3 (0.50) | SLC28A3L3MBTL1MAPTPYGBLGALS8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117129582-A | Substance evaluation method, pharmaceutical composition and application of sophora fruit product | 上海医药工业研究院有限公司 | 2023-11-28 | — | — | CN | claimed |
| CN-117129607-A | Processing method of sophora fruit, fingerprint and application thereof | 上海医药工业研究院有限公司 | 2023-11-28 | — | — | CN | claimed |
| CN-104231013-B | A kind of gastrodine Glehnilae and preparation method thereof and application | 上海现代哈森（商丘）药业有限公司 | 2016-06-29 | — | — | CN | claimed |
| CN-104628796-A | Gastrodin medicine, and composition and use thereof | LIU LI | 2015-05-20 | — | — | CN | claimed |
| CN-104231013-A | Gastrodin ferulate compound and preparation method and application of gastrodin ferulate compound | SHANGHAI MODERN HASEN SHANGQIU PHARMACEUTICAL CO LTD | 2014-12-24 | — | — | CN | claimed |
| CN-118695854-A | Food-related particles, production method and production device | 努利希尔有限公司 | 2024-09-24 | — | — | CN | disclosed |
| CN-117777217-A | Chemical preparation method of icariside D2 | 威海海洋职业学院 | 2024-03-29 | — | — | CN | disclosed |
| CN-117777217-A | Chemical preparation method of icariside D2 | 威海海洋职业学院 | 2024-03-29 | — | — | CN | disclosed |
| CN-117129582-A | Substance evaluation method, pharmaceutical composition and application of sophora fruit product | 上海医药工业研究院有限公司 | 2023-11-28 | — | — | CN | disclosed |
| CN-117129607-A | Processing method of sophora fruit, fingerprint and application thereof | 上海医药工业研究院有限公司 | 2023-11-28 | — | — | CN | disclosed |
| EP-4143297-A1 | PHENOL-RICH GRAPES | The State of Israel - Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) (IL) | 2023-03-08 | — | — | EP | disclosed |
| US-20200163983-A1 | SAPONIN COMPOUND TARGETING PD-1 AND APPLICATION THEREOF | SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) | 2020-05-28 | — | — | US | disclosed |
| CN-1418219-A | Glucopyranosyloxy benzylbenzene derivatives, medicinal compositions containing the same and intermediates for the prepararation of the derivatives | KISSEI PHARMACEUTICAL (JP) | 2003-05-14 | — | — | CN | disclosed |
| EP-1270584-A1 | GLUCOPYRANOSYLOXY BENZYLBENZENE DERIVATIVES, MEDICINAL COMPOSITIONS CONTAINING THE SAME AND INTERMEDIATES FOR THE PREPARATION OF THE DERIVATIVES | Kissei Pharmaceutical Co., Ltd. (JP) | 2003-01-02 | — | — | EP | disclosed |
| WO-2001062088-A2 | SAFENING HIGH CONCENTRATIONS OF PHYTOCATALYSTS | THE DOW CHEMICAL COMPANY (US) | 2001-08-30 | — | — | WO | disclosed |
| EP-0816375-A1 | GLYCOCONJUGATES OF OPIATED SUBSTANCES | ROLABO SL (ES) | 1998-01-07 | — | — | EP | disclosed |
| WO-1993024505-A1 | REDUCING INFLAMMATION BY TIME DEPENDENT ADMINISTRATION OF OLIGOSACCHARIDES GLYCOSIDES RELATED TO BLOOD GROUP DETERMINANTS | ALBERTA RESEARCH COUNCIL (CA) | 1993-12-09 | — | — | WO | disclosed |
| EP-0549665-A1 | POLY(FLUOROALKYL) SUGAR REAGENTS AND THEIR USE FOR SURFACE MODIFICATION | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1993-07-07 | — | — | EP | disclosed |
| WO-1992005444-A1 | POLY(FLUOROALKYL) SUGAR REAGENTS AND THEIR USE FOR SURFACE MODIFICATION | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-04-02 | — | — | WO | disclosed |
| CN-85103648-A | Production 4 '-demethyl epipodophyllotoxin-9-4, the novel method of 6-0-ethidine β-D pyranoglucose | — | 1986-11-19 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200163983-A1 | SAPONIN COMPOUND TARGETING PD-1 AND APPLICATION THEREOF | PDCD1, CD274, PDCD1LG2 | SLC28A3 2763/4885L3MBTL1 4038/4885MAPT 1840/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.